Your browser doesn't support javascript.
loading
Drug rechanneling: A novel paradigm for cancer treatment.
Kaushik, Itishree; Ramachandran, Sharavan; Prasad, Sahdeo; Srivastava, Sanjay K.
Afiliação
  • Kaushik I; Department of Immunotherapeutics and Biotechnology, and Center for Tumor Immunology and Targeted Cancer Therapy, Texas Tech University Health Sciences Center, Abilene, TX 79601, USA.
  • Ramachandran S; Department of Immunotherapeutics and Biotechnology, and Center for Tumor Immunology and Targeted Cancer Therapy, Texas Tech University Health Sciences Center, Abilene, TX 79601, USA.
  • Prasad S; Department of Immunotherapeutics and Biotechnology, and Center for Tumor Immunology and Targeted Cancer Therapy, Texas Tech University Health Sciences Center, Abilene, TX 79601, USA.
  • Srivastava SK; Department of Immunotherapeutics and Biotechnology, and Center for Tumor Immunology and Targeted Cancer Therapy, Texas Tech University Health Sciences Center, Abilene, TX 79601, USA. Electronic address: sanjay.srivastava@ttuhsc.edu.
Semin Cancer Biol ; 68: 279-290, 2021 01.
Article em En | MEDLINE | ID: mdl-32437876
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Descoberta de Drogas / Reposicionamento de Medicamentos / Neoplasias / Antineoplásicos Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Descoberta de Drogas / Reposicionamento de Medicamentos / Neoplasias / Antineoplásicos Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article